Liraglutide
Liraglutide for Diabetes Control
A proven therapy for improving blood sugar levels in type 2 diabetes.
Liraglutide for Weight Loss
Clinically effective in supporting long-term sustainable weight loss.
Liraglutide's Health Benefits
Enhancing glycemic control and promoting overall metabolic health.
Advancing Liraglutide Treatment
Partner with us to improve patient outcomes in diabetes and obesity.
Pal-Glu(OSu)-Obn
Pal-Glu(OSu)-Obn, or Nε-palmitoyl-L-glutamic acid γ-succinimide-2,3-dihydroxybenzenesulfonyl ester, is a specialized intermediate used in the synthesis of lipidated peptides, particularly those designed for therapeutic applications such as obesity and type 2 diabetes treatment. The palmitoyl group at the Nε position confers enhanced lipophilicity, aiding in the stability and tissue-targeting capabilities of the resulting peptide derivatives.
This compound plays a key role in the creation of GLP-1 receptor agonists and other peptide-based therapeutics by modifying the pharmacokinetic properties of the peptides, ensuring sustained action and improving efficacy. Pal-Glu(OSu)-Obn is often used in pharmaceutical research to develop long-acting drug formulations.
CAS No: 294855-89-3
>>Download COA
Application:
- Peptide Synthesis: Used in the creation of lipid-modified GLP-1 analogs and other therapeutic peptides.
- Pharmaceutical Development: Important in the synthesis of long-acting peptide drugs, especially those aimed at treating metabolic disorders.
- Targeted Drug Delivery: Enhances the stability and tissue-targeting properties of lipidated peptides.
- Biochemical Research: Utilized in the development of novel drug formulations and peptide-based therapeutics for various conditions.
Packing: Customized
Need more information/samples?